Assignee
JACKOWSKI GEORGE
CA·5 granted patents·36 pending applications·5 citations·filing 2001–2014
Top patents by PatentIndex Score
41 records- 0178US9119826B2Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levelsJACKOWSKI GEORGE·Filed 2012·Granted Sep 1, 2015·2 cites·10 claims
- 0273US8715648B2Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabeticsJACKOWSKI GEORGE·Filed 2012·Granted May 6, 2014·3 cites·37 claims
- 0363US2006211139A1Protein biopolymer markers predictive of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 0459US2006211143A1Fibronectin and fibrinogen biopolymer markers indicative of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 0559US2006211150A1Fibronectin and fibrinogen biopolymer markers indicative of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 0659US2006211142A1Fibronectin and fibrinogen biopolymer markers indicative of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 0759US2006211149A1Fibronectin and fibrinogen biopolymer markers indicative of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 0858US2006211147A1Protein biopolymer markers indicative of age matched controlJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 0956US8951514B2Statin and omega 3 fatty acids for reduction of apolipoprotein-B levelsJACKOWSKI GEORGE·Filed 2012·Granted Feb 10, 2015·0 cites·15 claims
- 1056US8952000B2Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular eventsJACKOWSKI GEORGE·Filed 2012·Granted Feb 10, 2015·0 cites·20 claims
- 1155US2006211141A1Protein biopolymer markers predictive of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 1255US2006211138A1Protein biopolymer markers predictive of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 1355US2006205091A1Protein biopolymer markers predictive of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 1455US2006211144A1Protein biopolymer markers indicative of age matched controlJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 1555US2006211148A1Protein biopolymer markers indicative of age matched controlJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 1655US2006211140A1Protein biopolymer markers predictive of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 1754US2007184507A1Methods for predicting outcome in traumatic brain injuryJACKOWSKI GEORGE·Filed 2007·Application pending·0 cites
- 1854US2012302639A1Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden deathJACKOWSKI GEORGE·Filed 2012·Application pending·0 cites
- 1954US2008096286A1Biopolymer marker indicative of disease state having a molecular weight of 1348 daltonsJACKOWSKI GEORGE·Filed 2007·Application pending·0 cites
- 2053US2006134699A1Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 2153US2006134700A1Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 2252US2007010029A1Protein biopolymer markers predictive of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 2352US2007009963A1Apolipoprotein biopolymer marker indicative of normal humanJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 2452US2006211048A1Biopolymer marker indicative of disease state having a molecular weight of 1211 daltonsJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 2552US2007010030A1Complement C3 precursor biopolymer markers indicative of insulin resistanceJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 2651US8263351B2Diagnostic methods for congestive heart failureJACKOWSKI GEORGE·Filed 2011·Granted Sep 11, 2012·0 cites·7 claims
- 2750US2015272920A1Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (cvd) and diabeticsJACKOWSKI GEORGE·Filed 2014·Application pending·0 cites
- 2850US2006024755A1Biopolymer marker indicative of disease state having a molecular weight of 1424 daltonsJACKOWSKI GEORGE·Filed 2005·Application pending·0 cites
- 2949US2009068676A1Diagnostic methods for congestive heart failureJACKOWSKI GEORGE·Filed 2007·Application pending·0 cites
- 3048US2006211070A1Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNPJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 3148US2006051814A1Methods for predicting outcome in traumatic brain injuryJACKOWSKI GEORGE·Filed 2005·Application pending·0 cites
- 3248US2012149042A1Methods for predicting outcome in traumatic brain injuryJACKOWSKI GEORGE·Filed 2011·Application pending·0 cites
- 3346US2007003974A1Cene-E biopolymer marker indicative of age matched controlJACKOWSKI GEORGE·Filed 2001·Application pending·0 cites
- 3445US2006134108A1Method for retarding or precluding Alzheimer's dementiaJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 3545US2006275831A1Complement C3 precursor biopolymer markers predictive of type II diabetesJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 3645US2007031979A1Protein biopolymer markers predictive of type II diabetesJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
- 3744US2006024761A1Protein biopolymer markers predictive of alzheimer's diseaseJACKOWSKI GEORGE·Filed 2005·Application pending·0 cites
- 3844US2006068505A1Biopolymer marker indicative of disease state having a molecular weight of 1077 daltonsJACKOWSKI GEORGE·Filed 2005·Application pending·0 cites
- 3944US2005287613A1Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNPJACKOWSKI GEORGE·Filed 2002·Application pending·0 cites
- 4040US2009093000A1Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers diseaseJACKOWSKI GEORGE·Filed 2001·Application pending·0 cites
- 4134US2006292703A1Biopolymer marker indicative of disease state having a molecular weight of 2753 daltonsJACKOWSKI GEORGE·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JACKOWSKI GEORGE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →